期刊文献+

Contemporary review of drug-induced pancreatitis: A different perspective 被引量:10

Contemporary review of drug-induced pancreatitis: A different perspective
下载PDF
导出
摘要 Although gallstone and alcohol use have been consid-ered the most common causes of acute pancreatitis, hundreds of frequently prescribed medications are as-sociated with this disease state. The true incidence is unknown since there are few population based studies available. The knowledge of drug induced acute pan-creatitis is limited by the availability and the quality of the evidence as the majority of data is extrapolated from case reports. Establishing a definitive causal rela-tionship between a drug and acute pancreatitis poses a challenge to clinicians. Several causative agent classifi-cation systems are often used to identify the suspected agents. They require regular updates since new drug induced acute pancreatitis cases are reported continu-ously. In addition, infrequently prescribed medications and herbal medications are often omitted. Furthermore, identification of drug induced acute pancreatitis with new medications often requires accumulation of post market case reports. The unrealistic expectation for a comprehensive list of medications and the multifacto-rial nature of acute pancreatitis call for a different ap-proach. In this article, we review the potential mecha-nisms of drug induced acute pancreatitis and providethe perspective of deductive reasoning in order to allow clinicians to identify potential drug induced acute pan-creatitis with limited data. Although gallstone and alcohol use have been consid-ered the most common causes of acute pancreatitis, hundreds of frequently prescribed medications are as-sociated with this disease state. The true incidence is unknown since there are few population based studies available. The knowledge of drug induced acute pan-creatitis is limited by the availability and the quality of the evidence as the majority of data is extrapolated from case reports. Establishing a definitive causal rela-tionship between a drug and acute pancreatitis poses a challenge to clinicians. Several causative agent classifi-cation systems are often used to identify the suspected agents. They require regular updates since new drug induced acute pancreatitis cases are reported continu-ously. In addition, infrequently prescribed medications and herbal medications are often omitted. Furthermore, identification of drug induced acute pancreatitis with new medications often requires accumulation of post market case reports. The unrealistic expectation for a comprehensive list of medications and the multifacto-rial nature of acute pancreatitis call for a different ap-proach. In this article, we review the potential mecha-nisms of drug induced acute pancreatitis and providethe perspective of deductive reasoning in order to allow clinicians to identify potential drug induced acute pan-creatitis with limited data.
出处 《World Journal of Gastrointestinal Pathophysiology》 CAS 2014年第4期405-415,共11页 世界胃肠病理生理学杂志(英文版)(电子版)
关键词 DRUG-INDUCED PANCREATITIS MECHANISM Drug-induced pancreatitis Mechanism
  • 相关文献

参考文献20

  • 1Nanne KH de Boer,Luc JJ Derijks,Lennard PL Gilissen,Daniel W Hommes,Leopold GJB Engels,Sybrand Y de Boer,Gijsbertus den Hartog,Piet M Hooymans,Anja BU M(?)kelburg,Barend D Westerveld,Anton HJ Naber,Chris JJ Mulder,Dirk J de Jong.On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprineor 6-mercaptopurine intolerant IBD patients[J].World Journal of Gastroenterology,2005,11(35):5540-5544. 被引量:4
  • 2Thomas W. Frick.The role of calcium in acute pancreatitis[J]. Surgery . 2012 (3)
  • 3Matteo Monami,Ilaria Dicembrini,Daniele Martelli,Edoardo Mannucci.Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials[J]. Current Medical Research & Opinion . 2011 (S3)
  • 4P.J. Wilde,B.S. Chu.Interfacial & colloidal aspects of lipid digestion[J]. Advances in Colloid and Interface Science . 2011 (1)
  • 5C William Wester,Ann Muir Thomas,Hermann Bussmann,Sikhulile Moyo,Joseph M Makhema,Tendani Gaolathe,Vladimir Novitsky,Max Essex,Victor deGruttola,Richard G Marlink.Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana[J]. AIDS . 2010
  • 6Whitney Y. Hung,Laura Kogelman,Gretchen Volpe,Mark Iafrati,Lisa Davidson.Tigecycline-induced acute pancreatitis: case report and literature review[J]. International Journal of Antimicrobial Agents . 2009 (5)
  • 7Balani, Anil R,Grendell, James H.Drug-Induced Pancreatitis: Incidence, Management and Prevention[J]. Drug Safety . 2008 (10)
  • 8Melanie Gilson,Laurence Moachon,Luc Jeanne,Valerie Dumaine,Luc Eyrolle,Philippe Morand,Mona Ben M’rad,Dominique Salmon.Acute pancreatitis related to tigecycline: Case report and review of the literature[J]. Scandinavian Journal of Infectious Diseases . 2008 (8)
  • 9Mitsuyoshi Suzuki,Toshiaki Shimizu,Takahiro Kudo,Hiromichi Shoji,Yoshikazu Ohtsuka,Yuichiro Yamashiro.Octreotide prevents l -asparaginase–induced pancreatic injury in rats[J]. Experimental Hematology . 2008 (2)
  • 10Nison Badalov,Robin Baradarian,Kadirawel Iswara,Jianjun Li,William Steinberg,Scott Tenner.Drug-Induced Acute Pancreatitis: An Evidence-Based Review[J]. Clinical Gastroenterology and Hepatology . 2007 (6)

二级参考文献10

  • 1Sandborn WJ.A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate[].The American journal of Gastroenterology.1996
  • 2Rutgeerts P,Van Assche G,Vermeire S.Optimizing anti-TNF treatment in inflammatory bowel disease[].Gastroenterology.2004
  • 3Ardizzone S,Bollard S,Manzionna G,Imbesi V,Colombo E,Bianchi PG.Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn’s disease: a randomised, investigator-blind study[].Digestive and Liver Disease.2003
  • 4Dubinsky MC,Lamothe S,Yang HY,Targan SR,Sinnett D,Theoret Y,Seidman EG.Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease[].Gastroenterology.2000
  • 5Present DH,Meltzer SJ,Krumholz MP,Wolke A,Korelitz BI.6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity[].Annals of Internal Medicine.1989
  • 6Hanauer SB,Present DH.The state of the art in the management of inflammatory bowel disease[].Revista de Gastroenterologia de Mexico.2003
  • 7Cuffari C,Hunt S,Bayless T.Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease[].Gut.2001
  • 8Bell SJ,Kamm MA.Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn’s disease[].Alimentary Pharmacology and Therapeutics.2000
  • 9Weinshilboum R.Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase[].Drug Metabolism and Disposition.2001
  • 10Dubinsky MC,Feldman EJ,Abreu MT,Targan SR,Vasiliauskas EA.Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine[].The American journal of Gastroenterology.2003

共引文献7

同被引文献52

引证文献10

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部